Literature DB >> 19846989

Further studies on the frequency of colorectal cancer in Crohn's colitis: an 11-year survey in the Northwest Stockholm County.

Carlos A Rubio1, Marjo Kapraali, Ragnar Befrits.   

Abstract

BACKGROUND: The frequency of colorectal carcinomas (CRC) evolving in patients with Crohn's colitis (CC) was assessed at the Danderyds University Hospital (DUH), one of two large hospitals in Northwest Stockholm County (NWSC). PATIENTS AND METHODS: A total of 121 patients with Crohn's disease (CD) were treated at this hospital between 1996 and 2006. All sections from colectomy specimens having CC and carcinoma were reviewed.
RESULTS: Of the 121 patients with CD, 79.4% (96/121) had CC. Of the 96 patients with CC, 6.3% (n=6) developed a CRC between 1996 and 2006. DISCUSSION: Recent studies at the other large hospital in NWSC showed that during the same period (1996-2006) 7.4% (n=21) of the 282 patients with CC, developed a CRC. During this 11-year period, 7.1% (n=27) of the 378 patients with CC seen at the two hospitals that treat the vast majority of patients with CD in NWSC developed a CRC. By comparison, only 0.29% or 5,566 patients (age-adjusted) out of the 1,900,000 inhabitants in the entire Stockholm County developed a CRC during the same period. These results, obtained at a comparative time-interval in the County, substantiate several recent meta-analysis and population-based studies on the high cancer risk in patients with Crohn disease.

Entities:  

Mesh:

Year:  2009        PMID: 19846989

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Biologic Therapies for Crohn's Disease: Update from the 2009 ACG Meeting.

Authors:  David G Binion
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-01

2.  Clinical presentation and diagnosis of intestinal adenocarcinoma in Crohn's disease: analysis of clinical predictors and of the life-time risk.

Authors:  Cesare Ruffolo; Marco Scarpa; Lino Polese; Francesco E D'Amico; Riccardo Boetto; Anna Pozza; Renata D'Incà; Davide Checchin; Giacomo Carlo Sturniolo; Nicolò Bassi; Imerio Angriman
Journal:  J Gastrointest Surg       Date:  2010-07-14       Impact factor: 3.452

Review 3.  Impact of medical therapies on inflammatory bowel disease complication rate.

Authors:  Catherine Reenaers; Jacques Belaiche; Edouard Louis
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

4.  The histopathological approach to inflammatory bowel disease: a practice guide.

Authors:  Cord Langner; Fernando Magro; Ann Driessen; Arzu Ensari; Gerassimos J Mantzaris; Vincenzo Villanacci; Gabriel Becheanu; Paula Borralho Nunes; Gieri Cathomas; Walter Fries; Anne Jouret-Mourin; Claudia Mescoli; Giovanni de Petris; Carlos A Rubio; Neil A Shepherd; Michael Vieth; Rami Eliakim; Karel Geboes
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.